Every US company we alert on
5,765 US-listed companies, ranked by market cap. Open any company to see every SEC filing alert we sent for it: 8-K material events, deals, capital raises, results, leadership changes and insider trades.
Sector
| # | Company | Sector | Market cap | Alerts | Latest |
|---|---|---|---|---|---|
| 1385 | Prestige Consumer Healthcare Inc.NYSE: PBH | Life Sciences | $2.28B | 2 | Financial ResultsNov 5, 2026 |
| 1391 | Perrigo Co plcNYSE: PRGO | Life Sciences | $2.25B | 2 | Financial ResultsNov 4, 2026 |
| 1392 | Celldex Therapeutics, Inc.NASDAQ: CLDX | Life Sciences | $2.25B | 3 | Financial ResultsNov 5, 2026 |
| 1406 | Beam Therapeutics Inc.NASDAQ: BEAM | Life Sciences | $2.17B | 3 | Financial ResultsNov 3, 2026 |
| 1415 | Palvella Therapeutics, Inc.NASDAQ: PVLA | Life Sciences | $2.11B | 7 | Insider SellingNov 12, 2026 |
| 1420 | Biohaven Ltd.NYSE: BHVN | Life Sciences | $2.08B | 5 | Investor PresentationNov 16, 2026 |
| 1422 | Immunome Inc.NASDAQ: IMNM | Life Sciences | $2.08B | 3 | Financial ResultsNov 9, 2026 |
| 1424 | Aurinia Pharmaceuticals Inc.NASDAQ: AUPH | Life Sciences | $2.07B | 2 | Financial ResultsOct 30, 2026 |
| 1438 | Replimune Group, Inc.NASDAQ: REPL | Life Sciences | $2.03B | 5 | Insider SellingNov 10, 2026 |
| 1452 | Septerna, Inc.NASDAQ: SEPN | Life Sciences | $1.98B | 6 | Insider SellingNov 16, 2026 |
| 1456 | First Tracks Biotherapeutics, Inc.NASDAQ: TRAX | Life Sciences | $1.96B | 5 | Financial ResultsNov 3, 2026 |
| 1459 | Vera Therapeutics, Inc.NASDAQ: VERA | Life Sciences | $1.95B | 3 | Financial ResultsNov 5, 2026 |
| 1462 | Harmony Biosciences Holdings, Inc.NASDAQ: HRMY | Life Sciences | $1.94B | 5 | Financial ResultsNov 4, 2026 |
| 1468 | Biocryst Pharmaceuticals IncNASDAQ: BCRX | Life Sciences | $1.92B | 2 | Financial ResultsNov 4, 2026 |
| 1471 | Trevi Therapeutics, Inc.NASDAQ: TRVI | Life Sciences | $1.89B | 2 | Financial ResultsNov 9, 2026 |
| 1472 | Zenas BioPharma, Inc.NASDAQ: ZBIO | Life Sciences | $1.89B | 4 | Capital RaiseNov 6, 2026 |
| 1483 | Maze Therapeutics, Inc.NASDAQ: MAZE | Life Sciences | $1.85B | 8 | Financial ResultsNov 9, 2026 |
| 1486 | Eton Pharmaceuticals, Inc.NASDAQ: ETON | Life Sciences | $1.84B | 10 | Insider SellingNov 12, 2026 |
| 1493 | Zymeworks Inc.NASDAQ: ZYME | Life Sciences | $1.83B | 7 | Insider SellingNov 16, 2026 |
| 1494 | Hemab Therapeutics Holdings, Inc.NASDAQ: COAG | Life Sciences | $1.83B | 3 | Financial ResultsNov 10, 2026 |
| 1499 | Recursion Pharmaceuticals, Inc.NASDAQ: RXRX | Life Sciences | $1.81B | 7 | Insider SellingNov 4, 2026 |
| 1501 | Agios Pharmaceuticals, Inc.NASDAQ: AGIO | Life Sciences | $1.8B | 4 | Financial ResultsNov 5, 2026 |
| 1517 | Braveheart Bio, Inc.NASDAQ: BRVE | Life Sciences | $1.75B | 3 | Financial ResultsNov 10, 2026 |
| 1520 | Stoke Therapeutics, Inc.NASDAQ: STOK | Life Sciences | $1.74B | 6 | Insider SellingNov 4, 2026 |
| 1541 | Supernus Pharmaceuticals, Inc.NASDAQ: SUPN | Life Sciences | $1.68B | 7 | M&A DealNov 2, 2026 |
| 1556 | Vir Biotechnology, Inc.NASDAQ: VIR | Life Sciences | $1.64B | 9 | Capital RaiseNov 16, 2026 |
| 1561 | Kailera Therapeutics, Inc.NASDAQ: KLRA | Life Sciences | $1.63B | 2 | Financial ResultsNov 4, 2026 |
| 1567 | Sarepta Therapeutics, Inc.NASDAQ: SRPT | Life Sciences | $1.62B | 3 | Financial ResultsNov 5, 2026 |
| 1569 | Ultragenyx Pharmaceutical Inc.NASDAQ: RARE | Life Sciences | $1.62B | 7 | Financial ResultsNov 4, 2026 |
| 1576 | Nurix Therapeutics, Inc.NASDAQ: NRIX | Life Sciences | $1.61B | 11 | Insider SellingNov 4, 2026 |
| 1586 | ADARx Pharmaceuticals, Inc.NASDAQ: ADRX | Life Sciences | $1.56B | 8 | Financial ResultsNov 12, 2026 |
| 1593 | Precigen, Inc.NASDAQ: PGEN | Life Sciences | $1.54B | 2 | Financial ResultsNov 5, 2026 |
| 1595 | uniQure N.V.NASDAQ: QURE | Life Sciences | $1.53B | 6 | Insider SellingNov 10, 2026 |
| 1601 | Sellas Life Sciences Group, Inc.NASDAQ: SLS | Life Sciences | $1.52B | 3 | Clinical Trial DataNov 17, 2026 |
| 1611 | Immunocore Holdings plcNASDAQ: IMCR | Life Sciences | $1.49B | 3 | Financial ResultsNov 6, 2026 |
| 1614 | Korsana Biosciences, Inc.NASDAQ: KRSA | Life Sciences | $1.49B | 2 | Financial ResultsNov 5, 2026 |
| 1619 | Rapport Therapeutics, Inc.NASDAQ: RAPP | Life Sciences | $1.47B | 15 | Financial ResultsNov 4, 2026 |
| 1624 | Pacira BioSciences, Inc.NASDAQ: PCRX | Life Sciences | $1.46B | 6 | M&A DealNov 17, 2026 |
| 1647 | Damora Therapeutics, Inc.NASDAQ: DMRA | Life Sciences | $1.39B | 2 | Financial ResultsNov 4, 2026 |
| 1648 | Lb Pharmaceuticals IncNASDAQ: LBRX | Life Sciences | $1.39B | 3 | Financial ResultsNov 5, 2026 |
| 1649 | Intellia Therapeutics, Inc.NASDAQ: NTLA | Life Sciences | $1.38B | 6 | Investor PresentationNov 13, 2026 |
| 1650 | UroGen Pharma Ltd.NASDAQ: URGN | Life Sciences | $1.38B | 3 | Financial ResultsNov 4, 2026 |
| 1655 | Anaptysbio, IncNASDAQ: ANAB | Life Sciences | $1.37B | 4 | Financial ResultsNov 12, 2026 |
| 1656 | Tyra Biosciences, Inc.NASDAQ: TYRA | Life Sciences | $1.36B | 3 | Financial ResultsNov 10, 2026 |
| 1661 | Nuvation Bio Inc.NYSE: NUVB | Life Sciences | $1.36B | 3 | Earnings CallNov 4, 2026 |
| 1663 | Generate Biomedicines, Inc.NASDAQ: GENB | Life Sciences | $1.35B | 3 | Financial ResultsNov 12, 2026 |
| 1670 | Novavax IncNASDAQ: NVAX | Life Sciences | $1.33B | 3 | Financial ResultsNov 5, 2026 |
| 1673 | Taysha Gene Therapies, Inc.NASDAQ: TSHA | Life Sciences | $1.32B | 2 | Financial ResultsNov 12, 2026 |
| 1676 | Ocular Therapeutix, IncNASDAQ: OCUL | Life Sciences | $1.32B | 8 | Insider SellingNov 9, 2026 |
| 1678 | Avalyn Pharma Inc.NASDAQ: AVLN | Life Sciences | $1.32B | 4 | Insider SellingNov 12, 2026 |
| 1680 | Innoviva, Inc.NASDAQ: INVA | Life Sciences | $1.31B | 2 | Financial ResultsNov 4, 2026 |
| 1692 | Mineralys Therapeutics, Inc.NASDAQ: MLYS | Life Sciences | $1.29B | 6 | Financial ResultsNov 4, 2026 |
| 1695 | Mannkind CorpNASDAQ: MNKD | Life Sciences | $1.27B | 2 | Financial ResultsNov 5, 2026 |
| 1703 | Nektar TherapeuticsNASDAQ: NKTR | Life Sciences | $1.25B | 5 | Investor MeetingNov 13, 2026 |
| 1707 | Amphastar Pharmaceuticals, Inc.NASDAQ: AMPH | Life Sciences | $1.24B | 2 | Financial ResultsNov 5, 2026 |
| 1709 | Omeros CorpNASDAQ: OMER | Life Sciences | $1.24B | 4 | Earnings CallNov 16, 2026 |
| 1726 | Opko Health, Inc.NASDAQ: OPK | Life Sciences | $1.2B | 5 | Insider SellingNov 5, 2026 |
| 1727 | Kardigan, Inc.NASDAQ: KARD | Life Sciences | $1.2B | 4 | Financial ResultsNov 12, 2026 |
| 1729 | Cronos Group Inc.NASDAQ: CRON | Life Sciences | $1.2B | 3 | Financial ResultsNov 5, 2026 |
| 1739 | Compass Pathways plcNASDAQ: CMPS | Life Sciences | $1.17B | 2 | Financial ResultsNov 3, 2026 |
| 1741 | Vor Biopharma Inc.NASDAQ: VOR | Life Sciences | $1.17B | 2 | Licensing DealNov 12, 2026 |
| 1748 | Inhibrx Biosciences, Inc.NASDAQ: INBX | Life Sciences | $1.15B | 4 | Financial ResultsNov 13, 2026 |
| 1775 | Harrow, Inc.NASDAQ: HROW | Life Sciences | $1.09B | 4 | Investor PresentationNov 16, 2026 |
| 1777 | Alto Neuroscience, Inc.NYSE: ANRO | Life Sciences | $1.09B | 3 | Financial ResultsNov 10, 2026 |
| 1790 | Jade Biosciences, Inc.NASDAQ: JBIO | Life Sciences | $1.06B | 4 | Earnings CallNov 13, 2026 |
| 1812 | Seaport Therapeutics, Inc.NASDAQ: SPTX | Life Sciences | $1.02B | 3 | Insider BuyingNov 4, 2026 |
| 1825 | Cryoport, Inc.NASDAQ: CYRX | Life Sciences | $1B | 4 | Insider SellingNov 12, 2026 |
| 1829 | MoonLake ImmunotherapeuticsNASDAQ: MLTX | Life Sciences | $998M | 2 | Financial ResultsNov 4, 2026 |
| 1833 | Savara IncNASDAQ: SVRA | Life Sciences | $985M | 1 | Financial ResultsNov 9, 2026 |
| 1841 | Verastem, Inc.NASDAQ: VSTM | Life Sciences | $970M | 7 | Insider SellingNov 5, 2026 |
| 1866 | Odyssey Therapeutics, Inc.NASDAQ: ODTX | Life Sciences | $931M | 3 | Financial ResultsNov 4, 2026 |
| 1882 | Corvus Pharmaceuticals, Inc.NASDAQ: CRVS | Life Sciences | $894M | 3 | Insider BuyingNov 13, 2026 |
| 1903 | MeiraGTx Holdings plcNASDAQ: MGTX | Life Sciences | $854M | 5 | Financial ResultsNov 12, 2026 |
| 1912 | Latigo Biotherapeutics, Inc.NASDAQ: LTGO | Life Sciences | $835M | 2 | Financial ResultsNov 5, 2026 |
| 1920 | Rigel Pharmaceuticals IncNASDAQ: RIGL | Life Sciences | $823M | 1 | Financial ResultsNov 5, 2026 |
| 1924 | Syndax Pharmaceuticals IncNASDAQ: SNDX | Life Sciences | $815M | 3 | Financial ResultsNov 2, 2026 |
| 1938 | Ironwood Pharmaceuticals IncNASDAQ: IRWD | Life Sciences | $803M | 3 | Financial ResultsNov 5, 2026 |
| 1943 | Collegium Pharmaceutical, IncNASDAQ: COLL | Life Sciences | $790M | 3 | Financial ResultsNov 5, 2026 |
| 1947 | Monte Rosa Therapeutics, Inc.NASDAQ: GLUE | Life Sciences | $783M | 3 | Financial ResultsNov 5, 2026 |
| 1948 | Oric Pharmaceuticals, Inc.NASDAQ: ORIC | Life Sciences | $782M | 5 | Financial ResultsNov 16, 2026 |
| 1952 | Lexicon Pharmaceuticals, Inc.NASDAQ: LXRX | Life Sciences | $779M | 3 | Insider BuyingNov 9, 2026 |
| 1956 | Ardelyx, Inc.NASDAQ: ARDX | Life Sciences | $772M | 2 | Financial ResultsNov 3, 2026 |
| 1959 | Obsidian Therapeutics, Inc.NASDAQ: OBX | Life Sciences | $764M | 2 | Financial ResultsNov 12, 2026 |
| 1964 | Prime Medicine, Inc.NASDAQ: PRME | Life Sciences | $762M | 4 | Financial ResultsNov 12, 2026 |
| 1974 | Aura Biosciences, Inc.NASDAQ: AURA | Life Sciences | $751M | 2 | Financial ResultsNov 9, 2026 |
| 1988 | Solid Biosciences Inc.NASDAQ: SLDB | Life Sciences | $723M | 2 | Financial ResultsNov 4, 2026 |
| 2006 | QuidelOrtho CorpNASDAQ: QDEL | Life Sciences | $701M | 4 | Financial ResultsNov 4, 2026 |
| 2024 | Apnimed, Inc.NASDAQ: APMD | Life Sciences | $678M | 3 | Financial ResultsNov 16, 2026 |
| 2029 | Attovia Therapeutics, Inc.NASDAQ: ATTO | Life Sciences | $672M | 2 | Financial ResultsNov 9, 2026 |
| 2032 | Janux Therapeutics, Inc.NASDAQ: JANX | Life Sciences | $668M | 2 | Financial ResultsNov 5, 2026 |
| 2035 | Achieve Life Sciences, Inc.NASDAQ: QUIT | Life Sciences | $667M | 3 | Financial ResultsNov 10, 2026 |
| 2040 | Nuvectis Pharma, Inc.NASDAQ: NVCT | Life Sciences | $657M | 2 | Financial ResultsNov 4, 2026 |
| 2047 | Kura Oncology, Inc.NASDAQ: KURA | Life Sciences | $651M | 3 | Insider BuyingNov 16, 2026 |
| 2050 | Bicara Therapeutics Inc.NASDAQ: BCAX | Life Sciences | $647M | 2 | Financial ResultsNov 9, 2026 |
| 2052 | Olema Pharmaceuticals, Inc.NASDAQ: OLMA | Life Sciences | $645M | 4 | Other 8-K FilingNov 12, 2026 |
| 2062 | Design Therapeutics, Inc.NASDAQ: DSGN | Life Sciences | $635M | 2 | Financial ResultsNov 4, 2026 |
| 2067 | Immix Biopharma, Inc.NASDAQ: IMMX | Life Sciences | $627M | 4 | Business UpdateNov 12, 2026 |
| 2071 | Arbutus Biopharma CorpNASDAQ: ABUS | Life Sciences | $619M | 4 | Investor PresentationNov 12, 2026 |
| 2072 | Cullinan Therapeutics, Inc.NASDAQ: CGEM | Life Sciences | $617M | 8 | Financial ResultsNov 10, 2026 |
| 2073 | Surrozen, Inc.NASDAQ: SRZN | Life Sciences | $616M | 7 | Capital RaiseNov 16, 2026 |